Mounjaro farts: why tirzepatide causes excess wind and what you can do

Flatulence and burping are recognised gastrointestinal side effects of tirzepatide, listed in the Mounjaro prescribing information and confirmed in clinical trial reporting.
Slowed gastric emptying means food and gas move through the digestive tract more slowly than usual, which is the primary driver of increased wind on Mounjaro.
Dietary choices (particularly high-fat foods, carbonated drinks and foods that ferment quickly) can significantly worsen wind while the gut is adjusting to tirzepatide.
For the majority of people, wind and bloating settle within a few weeks of starting a dose; if symptoms are severe or persistent, discuss them with your prescriber rather than stopping treatment unilaterally.

Excess wind and flatulence are among the digestive side effects reported by people taking Mounjaro (tirzepatide). They occur because tirzepatide slows the movement of food through the gut, altering the way the digestive system processes what you eat — a well-documented effect tied to how the medicine works at both GIP and GLP-1 receptors. For most people, it is a temporary nuisance rather than a reason to stop treatment, and it tends to ease as the body adjusts. Like all GLP-1 and dual-agonist medicines, Mounjaro is a prescription-only medicine requiring clinical assessment before it is prescribed.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence says, and the practical steps that actually help

What clinical trial data tells us about wind and bloating on tirzepatide

The SURMOUNT-1 trial (published in the New England Journal of Medicine and involving 2,539 adults with obesity) recorded gastrointestinal side effects as the most common adverse events for participants on tirzepatide. Nausea, diarrhoea and vomiting received the most attention in trial reporting, but the broader GI category included flatulence, abdominal distension and eructation (belching). These effects were most pronounced in the first weeks of treatment and after each dose increase, and they were generally described as mild to moderate in severity. The underlying reason is well understood: tirzepatide activates both GIP and GLP-1 receptors, which together slow gastric emptying — the rate at which food leaves the stomach and enters the small intestine. When digestion is slower, bacteria in the large bowel have more time to ferment undigested carbohydrates, producing gas as a byproduct. This is the same process that makes high-fibre foods gassy, but amplified by a change in gut transit time. Understanding that it is a predictable pharmacological effect, rather than a sign something has gone wrong, can make it considerably easier to manage. The NHS tirzepatide medicines page lists flatulence and burping among the common or very common side effects; the NHS notes they are usually temporary.

Why certain foods make Mounjaro wind much worse

With gastric emptying already slowed by tirzepatide, the gut becomes noticeably more sensitive to foods that would cause wind under normal circumstances. High-fat meals sit in the stomach for longer, which increases discomfort and bloating. Carbonated drinks add gas directly. Foods rich in fermentable carbohydrates (onions, garlic, beans, lentils, cabbage, leeks, cauliflower) produce more gas than usual because they reach the large bowel partly undigested. Artificial sweeteners, common in low-calorie drinks and protein bars, can have a similar fermenting effect in some people. The practical implication is that dietary choices have an outsized impact on wind while you are on Mounjaro, particularly in the first four to eight weeks of a new dose. Many people find that spreading meals into smaller portions across the day reduces the pressure on a slowed digestive system. Eating slowly and chewing thoroughly helps. Reducing fizzy drinks is usually one of the quickest wins. None of this means permanently eliminating foods you enjoy; it is about calibrating intake while the gut adjusts. Our detailed page on managing wind on Mounjaro covers practical strategies in more depth. If you are also curious about how food choices interact with the broader question of why weight loss can plateau on Mounjaro, diet quality plays a role there too.

When wind on Mounjaro is worth mentioning to a prescriber

Most people experience some increase in wind, particularly at 2.5mg and again with each subsequent dose step, and if you are researching Mounjaro 2 as part of your titration journey, knowing which digestive effects to expect at that stage can help you prepare. What warrants attention is wind that arrives alongside severe or persistent abdominal pain, especially pain that radiates towards the back, with or without vomiting. That pattern is not typical of ordinary flatulence and could indicate a more serious gastrointestinal condition such as pancreatitis, which the MHRA highlighted in a Drug Safety Update for GLP-1 medicines in January 2026. Seek urgent medical help for that combination of symptoms rather than waiting for your next prescription review. Separately, if wind is accompanied by oily or loose stools that are difficult to flush, that can suggest fat malabsorption; it is worth flagging even if it is not an emergency. And if the flatulence is simply disruptive (affecting confidence at work or in social situations, which is a fair reason to raise it) that is also worth a conversation. You can reach our aftercare team seven days a week, or report any suspected side effects directly to the MHRA via the Yellow Card scheme. Prescribers often have practical suggestions that make the adjustment period considerably shorter. One question our prescribers hear regularly: should I slow down my dose increase because of digestive side effects? The answer is sometimes yes, and it is entirely reasonable to discuss a slower titration schedule. That decision belongs with your clinician, not a self-help forum.

How Mounjaro is prescribed and what to do if you are thinking about starting

Tirzepatide is licensed in the UK for weight management in adults with a BMI of 30 or above, or 27 and above where a weight-related health condition is present. Lower thresholds can apply for some ethnic backgrounds under UK guidance. A prescriber assesses the full clinical picture before any prescription is issued, current medicines, relevant health history, and whether the side-effect profile is appropriate for you individually. Understanding likely digestive side effects upfront, including wind, is part of that conversation, and it can help you plan practically before your first pen arrives. If you have been exploring whether it is possible to obtain Mounjaro fara reteta, it is important to understand that in the UK a valid prescription from a registered clinician is always required before treatment can be dispensed. For context on what the wider treatment journey looks like, the Mounjaro treatment overview and tirzepatide information page both cover the mechanism, evidence and eligibility criteria. If you are weighing up whether Mounjaro or another option is right for your situation, the weight-loss treatment overview sets out the licensed options. At nume, every consultation is read the same day by a GPhC-registered Independent Prescriber, a real clinician, not an automated system. If you are ready to take the next step, speak to our prescribers through a free consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions